LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Kodu・Aktsiate loetelu・ESPERION THERAPEUTICS INC

ESPERION THERAPEUTICS INC

Suletud

Sektor Tervishoid

1.65 -4.07

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.65

Max

1.68

Põhinäitajad
By Trading Economics
Sissetulek	-41M
Müük	-1.7M 32M
Aktsiakasum	-0.5
Kasumimarginaal	-121.434
Töötajad	240
EBITDA	-28M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+378.18 upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	5. nov 2024

Turustatistika
By TradingEconomics
Turukapital	-99M 516M
Eelmine avamishind	5.72
Eelmine sulgemishind	1.65

Uudiste sentiment

By Acuity

50%

94 / 365 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bearish Evidence

N/A / 1.7 Toetus ja vastupanu

ESPERION THERAPEUTICS INC Graafik

Seotud uudised

25. märts 2024, 15:18 UTC

Suurimad hinnamuutused turgudel

Esperion Shares Continue Rise After Friday's FDA Approval for Nexlizet, Nexletol

22. märts 2024, 15:34 UTC

Suurimad hinnamuutused turgudel

Esperion Therapeutics Gets CHMP Positive Opinion for Cholesterol Medications

Võrdlus sarnastega

Hinnamuutus

ESPERION THERAPEUTICS INC Prognoos

Hinnasiht

By TipRanks

378.18% tõus

12 kuu keskmine prognoos

Keskmine 7.89 USD 378.18%

Kõrge 16 USD

Madal 2.55 USD

Põhineb 4 Wall Streeti analüütiku instrumendi ESPERION THERAPEUTICS INC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

4 ratings

Osta

Hoia

Müü

Põhineb 4 analüütiku instrumendi ESPERION THERAPEUTICS INC aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

N/A / 1.7Toetus ja vastupanu

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

94 / 365 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest ESPERION THERAPEUTICS INC

Esperion Therapeutics, Inc. is a lipid management company. The Company is a pharmaceutical company focused on developing and commercializing oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). Its bempedoic acid and the bempedoic acid / ezetimibe combination tablets are oral, once-daily, non-statin, LDL-C lowering medicines for patients with atherosclerotic cardiovascular disease (ASCVD), or heterozygous familial hypercholesterolemia (HeFH). Its products include NEXLETOL, NILEMDO, NEXLIZET and NUSTENDI. NEXLETOL and NILEMDO are ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C by reducing cholesterol biosynthesis and up-regulating the LDL receptors. NEXLIZET and NUSTENDI contains bempedoic acid and ezetimibe and lowers elevated LDL-C through complementary mechanisms of action by inhibiting cholesterol synthesis in the liver and absorption in the intestine.